๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of insulin on glucagon secretion mediated via glucose metabolism of pancreatic a cells in ducks

โœ Scribed by F. Laurent; R. Gross; M. Lakili; P. Mialhe


Publisher
Springer
Year
1981
Tongue
English
Weight
607 KB
Volume
20
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Divergent effect of glucagon antibodies
โœ K. Tan; G. Atabani; V. Marks ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 409 KB

The effects of glucose and arginine on insulin secretion in the presence of glucagon antibodies were investigated in rats in vivo. In contrast to controls, animals given glucagon antibodies showed an inhibition of arginine-stimulated (p less than 0.001), but not glucose-stimulated, insulin secretion

The modulatory effect of the hypothalamu
โœ A. B. Steffens ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› Springer ๐ŸŒ English โš– 633 KB

Rats were provided both with brain cannulas, to permit infusion of fluids in the ventromedial and lateral hypothalamic areas (resp. VMH and LH), and with two heart catheters. In this way infusions of fluids and withdrawal of blood could be done in unanesthetized free moving animals. Infusion of nore

Abnormal glucagon response to arginine a
โœ T. Hamaguchi; H. Fukushima; M. Uehara; S. Wada; T. Shirotani; H. Kishikawa; K. I ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 710 KB

An excessive glucagon secretion to intravenous arginine infusion was found in obese hyperinsulinaemic patients with glucose intolerance. This study was designed to determine whether the glucagon hyperresponsiveness to arginine in these patients would improve by insulin infused at a high enough dose

Effect of islet activating protein on gl
โœ C. A. Re; M. C. Veroni; R. G. Larkins ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 625 KB

The effect of islet activating protein on glucose tolerance, insulin secretion and insulin responsiveness was studied in the NZO mouse, a model of non-insulin dependent diabetes and obesity. A single IV injection of 5 ng/g body weight islet activating protein markedly lowered plasma glucose and the